Mannkind (MNKD) Intangibles (2022 - 2026)
Mannkind (MNKD) reported Intangibles of $5.0 million for Q1 2026, down 3.7% year-over-year from $5.2 million in Q1 2025, and down 0.95% quarter-over-quarter from $5.1 million in Q4 2025.
Mannkind (MNKD) Intangibles (2022 - 2026) Analysis & Trends
Mannkind (MNKD) has 5 years of Intangibles data on file, last reported at $5.0 million in Q1 2026.
- Intangibles for Q1 2026 came in at $5.0 million, down 3.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 3.7% YoY), and the FY2025 annual result was $5.1 million, down 3.67% from the prior year.
- Intangibles eased to $5.0 million in Q1 2026 per MNKD's latest filing, from $5.1 million in the prior quarter.
- Over five years, Intangibles peaked at $5.3 million in Q3 2024 and troughed at $1.0 million in Q2 2024.
- A 5-year average of $2.9 million and a median of $1.3 million in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2023 and 2025: Intangibles slipped 20.5% in 2023, then soared 400.39% in 2025.
- A 5-year view of Intangibles shows it stood at $1.2 million in 2022, then decreased by 6.94% to $1.1 million in 2023, then surged by 390.68% to $5.3 million in 2024, then dropped by 3.67% to $5.1 million in 2025, then retreated by 0.95% to $5.0 million in 2026.
- Business Quant data shows MNKD's Intangibles at $5.0 million in Q1 2026, $5.1 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 7.73 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 5.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.02 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 5.22 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | 1.07 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.15 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.40 Mn |